Denis M. O'Donnell
Corporate Officer/Principal at Seaside Capital Management LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gale Smith | M | - | 20 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Condella | M | 70 | 8 years | |
| Gary Evans | M | 67 | 23 years | |
| Rahul Singhvi | M | 59 | 7 years | |
| Norman M. Meier | M | 85 | 13 years | |
| Robert Mills | M | 71 | 9 years | |
| Jeffrey Church | M | 67 | 1 years | |
| Evdoxia E. Kopsidas | F | 59 | 3 years | |
| Valerie Lynne Andrews | F | 64 | 10 years | |
| John A. Lambert | M | 71 | 3 years | |
| Dennis W. Genge | M | 71 | - | |
| John O. Marsh | M | 97 | 23 years | |
| Edward A. Blechschmidt | M | 71 | 10 years | |
| George Wilkinson | M | 68 | 5 years | |
| Stephen Kasnet | M | 78 | 11 years | |
| Michael McManus | M | 81 | - | |
| James A. Meer | M | 78 | 3 years | |
| Richard F. Maradie | M | 75 | 1 years | |
| Michael Ritz | M | 56 | 1 years | |
| Jim Robinson | M | - | 3 years | |
| Robin Robinson | M | 68 | 9 years | |
| Shen Luk | M | - | 18 years | |
| Pincus Steven | M | - | - | |
| George W. Creasy | M | 69 | 9 years | |
| Len Stigliano | M | 76 | - | |
| Penny M. Heaton | M | 59 | - | |
| James M. Robinson | M | - | 3 years | |
| Jane E. Hager | F | 77 | 7 years | |
| James Scott Crofton | M | 72 | 5 years | |
| Thomas P. Monath | M | 83 | 3 years | |
| Michael McGrane | M | 74 | 11 years | |
| David J. Weissberg | M | 69 |
CytoCore, Inc.
 CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | 1 years |
| Raymond Joseph Hage | M | 56 | 6 years | |
| Anthony R. Campbell | M | 76 | 2 years | |
| Nelson M. Sims | M | 76 | 2 years | |
| Ronald H. Walker | M | 86 | - | |
| Mitchell J. Kelly | M | - | - | |
| J. Michael Lazarus | M | - | - | |
| Ford R. Lynch | M | 77 | - | |
| Peter P. Gombrich | M | - |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | - |
| Selwyn P. Oskowitz | M | 78 | 11 years | |
| David L. Weinberg | M | 78 | 9 years | |
| James Tananbaum | M | 60 | 3 years | |
| Robert C. Strauss | M | 82 | - | |
| Anthony Blandin | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 45 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Denis M. O'Donnell
- Personal Network
